Zena Therapeutics Inc., founded in 2021, is an emerging United States-based company paving new pathways in drug discovery with a unique emphasis on patient safety, encapsulated by their slogan: "An innovative drug discovery company focused on patient safety."
Undergoing rapid development, Zena Therapeutics has successfully attracted early-stage investment, highlighted by a recent $500.00K Seed investment secured on 01 September 2023. While specific investor details are unlisted, this funding marks a critical step in fostering their growth trajectory.
This investment is poised to bolster their capabilities, potentially enhancing their market position as they continue to innovate in a competitive landscape. With a foundation in innovation and patient-centered approaches, Zena Therapeutics represents a promising opportunity for investors seeking to back pioneering advancements in the pharmaceutical sector.